ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Pennsylvania » Geriatric Medicine

Top Geriatric Medicine Prescribers in Pennsylvania

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
STEVEN LEWIS D.O.

Geriatric Medicine

48,952

$2.67M

998
853 are 65+

22%
patients receiving schedule two controlled substances

Avg: 11%

11%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $52

JERRY COHEN D.O.

Geriatric Medicine

44,481

$3.15M

993
774 are 65+

21%
patients receiving schedule two controlled substances

Avg: 11%

13%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$71
Average prescription price

Avg: $52

NORMAN FREY DO

Geriatric Medicine

28,959

$1.47M

690
596 are 65+

11%
patients receiving schedule two controlled substances

Avg: 11%

23%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $52

NEELOFER SOHAIL MD

Geriatric Medicine

25,515

$727K

385
354 are 65+

21%
patients receiving schedule two controlled substances

Avg: 11%

22%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$28
Average prescription price

Avg: $52

ALBERT ZANETTI D.O.

Geriatric Medicine

18,877

$1.39M

422
400 are 65+

9%
patients receiving schedule two controlled substances

Avg: 11%

14%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 24%

$73
Average prescription price

Avg: $52

AMBROSE PETERMAN DO

Geriatric Medicine

16,439

$798K

514
483 are 65+

6%
patients receiving schedule two controlled substances

Avg: 11%

9%
patients receiving schedule three controlled substances

Avg: 7%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $52

JAMES HARTY MD

Geriatric Medicine

15,699

$804K

317
294 are 65+

22%
patients receiving schedule two controlled substances

Avg: 11%

14%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $52

DALE HURSH MD

Geriatric Medicine

15,342

$577K

426
421 are 65+

15%
patients receiving schedule two controlled substances

Avg: 11%

11%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$38
Average prescription price

Avg: $52

LEON KRAYBILL MD

Geriatric Medicine

15,269

$547K

411
409 are 65+

18%
patients receiving schedule two controlled substances

Avg: 11%

16%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$36
Average prescription price

Avg: $52

MENG-CHAO LEE D.O.

Geriatric Medicine

15,189

$791K

309
289 are 65+

25%
patients receiving schedule two controlled substances

Avg: 11%

5%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $52

J WIECZOREK MD

Geriatric Medicine

14,687

$782K

438
403 are 65+

10%
patients receiving schedule two controlled substances

Avg: 11%

14%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $52

RAYMOND HAUSER M.D.

Geriatric Medicine

12,349

$595K

209
207 are 65+

21%
patients receiving schedule two controlled substances

Avg: 11%

8%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $52

BARRY MARKS DO

Geriatric Medicine

12,201

$501K

432
340 are 65+

3%
patients receiving schedule two controlled substances

Avg: 11%

4%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$41
Average prescription price

Avg: $52

NICOL JOSEPH DO

Geriatric Medicine

11,918

$578K

360
319 are 65+

20%
patients receiving schedule two controlled substances

Avg: 11%

3%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $52

KRISTEN NEBEL DO

Geriatric Medicine

11,110

$548K

384
381 are 65+

13%
patients receiving schedule two controlled substances

Avg: 11%

10%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $52

MARY-ANNE OST M.D.

Geriatric Medicine

10,848

$659K

453
405 are 65+

7%
patients receiving schedule two controlled substances

Avg: 11%

3%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$61
Average prescription price

Avg: $52

RONALD UNICE D.O.

Geriatric Medicine

10,537

$457K

273
227 are 65+

9%
patients receiving schedule two controlled substances

Avg: 11%

10%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$43
Average prescription price

Avg: $52

EMILY WILLIAMS MD

Geriatric Medicine

10,267

$427K

379
193 are 65+

0%
patients receiving schedule two controlled substances

Avg: 11%

0%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$42
Average prescription price

Avg: $52

DONNA MILLER DO

Geriatric Medicine

9,755

$378K

309
299 are 65+

18%
patients receiving schedule two controlled substances

Avg: 11%

10%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$39
Average prescription price

Avg: $52

LINDA TOMKO M.D.

Geriatric Medicine

9,685

$478K

280
265 are 65+

18%
patients receiving schedule two controlled substances

Avg: 11%

0%
patients receiving schedule three controlled substances

Avg: 7%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $52

MANDELL MUCH D.O.

Geriatric Medicine

9,435

$586K

159
158 are 65+

15%
patients receiving schedule two controlled substances

Avg: 11%

10%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $52

FARIAL RAWJI M.D

Geriatric Medicine

9,358

$560K

458
417 are 65+

0%
patients receiving schedule two controlled substances

Avg: 11%

9%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$60
Average prescription price

Avg: $52

DANIEL JANIAK DO

Geriatric Medicine

9,342

$515K

410
354 are 65+

6%
patients receiving schedule two controlled substances

Avg: 11%

17%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $52

PHILIP GELACEK M.D.

Geriatric Medicine

9,161

$714K

763
694 are 65+

4%
patients receiving schedule two controlled substances

Avg: 11%

4%
patients receiving schedule three controlled substances

Avg: 7%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 24%

$78
Average prescription price

Avg: $52

ROBERT VAUGHN M.D.

Geriatric Medicine

8,515

$349K

144
142 are 65+

21%
patients receiving schedule two controlled substances

Avg: 11%

0%
patients receiving schedule three controlled substances

Avg: 7%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$41
Average prescription price

Avg: $52

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank